First American Trust, Fsb Amgen Inc Transaction History

First American Trust, Fsb

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $157,273 - $208,587	-863 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $163,288 - $209,881	863 New	863 $208,000
Q4 2018 Jan 11, 2019	SELL	$178.4 - $208.25 $262,248 - $306,127	-1,470 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$185.29 - $208.89 $17,046 - $19,217	-92 Reduced 5.89%	1,470 $305,000
Q2 2018 Jul 06, 2018	BUY	$166.05 - $186.51 $259,370 - $291,328	1,562 New	1,562 $289,000

3,173

419M

8.25M

6.39M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of First American Trust, Fsb, based on Form 13F filings with the SEC.

Stay updated on First American Trust, Fsb with notifications on news.